InvestorsHub Logo
Followers 56
Posts 5540
Boards Moderated 0
Alias Born 11/04/2011

Re: nerby post# 148812

Tuesday, 05/24/2016 6:56:28 PM

Tuesday, May 24, 2016 6:56:28 PM

Post# of 402945
I think today is the first time Leo mentions eczema in the PR. Eczema drugs are quite valuable. Just one week ago Pfizer acquired Anacor for $5.2B.

Pfizer's Anacor deal showcases new wave of eczema therapies

"More than two dozen drugmakers are working on novel medicines to treat the condition affecting about 20 million Americans, also known as atopic dermatitis, and Pfizer's $5.2 billion deal positions it to become a market leader.

Anacor's steroid-free topical ointment crisaborole is the first of the new treatments to be reviewed by U.S. regulators. An injectable therapy called dupilumab from Regeneron Pharmaceuticals Inc (REGN.O) is expected to be submitted for U.S. approval later this year."

http://www.reuters.com/article/us-health-eczema-analysis-idUSKCN0Y80CX

Warning: Do NOT look at images of eczema before or after dinner. =)

Is it just me, or has the word "eczema" previously turned up when CTIX discussed Prurisol?




FUD - Fear, uncertainty and doubt, is generally a strategic attempt to influence perception by disseminating negative and dubious or false information.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News